CHEK1 and cancer: Particularly, it was reported that enhanced CHK1 activity is correlated with cancer resistance, and thus CHK1 inhibitors showed synergistic cancer therapy efficacy together with chemotherapeutics including gemcitabine and cisplatin [28].